Monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended 31, March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
iSERA Lifesciences Limited has submitted its quarterly monitoring agency report for the Rs. 8.08 crore Rights Issue proceeds. The report, issued by Infomerics Valuation and Rating Limited, confirms zero deviation from the stated objects of the issue for Q4 FY2025-26 (ending March 31, 2026). The filing complies with SEBI ICDR Regulations 2018 and LODR Regulations 2015 requirements. This is a routine regulatory compliance submission confirming that the company is utilizing the raised funds as originally intended.
Positive signal for shareholders as the monitoring agency confirms no misuse or deviation of Rights Issue proceeds. The clean report indicates proper fund deployment and adherence to regulatory norms, which supports investor confidence in corporate governance.